Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer

作者: Ayesha S. Bryant , Robert James Cerfolio

DOI: 10.1097/JTO.0B013E31817C60C7

关键词:

摘要: Objective Examination of factors that may contribute to racial disparity among those with lung cancer has been thwarted by heterogeneous treatment and staging strategies, limited national registry socioeconomic follow-up data. This study examines a decades worth data better elucidate these in cohort staged or treated using homogeneous algorithms. Methods A nested case-control patients non-small cell (NSCLC). White were matched 4:1 African American on age, gender, comorbidities, performance status, stage. All underwent clinical pathologic one physician similar staged-based Socioeconomic status was assessed annual income per capita, insurance education level. The primary outcome survival rate. Results Among the 930 this series, Americans more likely be smokers (p Conclusions Given uniform staging, treatment, overall rates for NSLC are similar.

参考文章(23)
Cummings Km, Giovino G, Mendicino Aj, Cigarette advertising and black-white differences in brand preference. Public Health Reports. ,vol. 102, pp. 698- 701 ,(1987)
Charles C. Canver, Vincent A. Memoli, Penny L. Vanderveer, Christine A. Dingivan, Robert M. Mentzer, Sex hormone receptors in non-small-cell lung cancer in human beings The Journal of Thoracic and Cardiovascular Surgery. ,vol. 108, pp. 153- 157 ,(1994) , 10.1016/S0022-5223(94)70232-2
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, M. J. Thun, Cancer statistics, 2006. CA: A Cancer Journal for Clinicians. ,vol. 56, pp. 106- 130 ,(2006) , 10.3322/CANJCLIN.56.2.106
M. V. Graham, L. M. Geitz, R. Byhardt, S. Asbell, M. Roach, R. C. Urtasun, W. J. Curran, P. Lattin, A. H. Russell, J. D. Cox, Comparison of Prognostic Factors and Survival Among Black Patients and White Patients Treated With Irradiation for Non-Small-Cell Lung Cancer Journal of the National Cancer Institute. ,vol. 84, pp. 1731- 1735 ,(1992) , 10.1093/JNCI/84.22.1731
Pasi A. Jänne, Sarada Gurubhagavatula, Beow Y. Yeap, Joan Lucca, Patricia Ostler, Arthur T. Skarin, Panos Fidias, Thomas J. Lynch, Bruce E. Johnson, Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study Lung Cancer. ,vol. 44, pp. 221- 230 ,(2004) , 10.1016/J.LUNGCAN.2003.12.014
Jonathan Samet, Choice of Cancer Therapy Varies With Age of Patient JAMA: The Journal of the American Medical Association. ,vol. 255, pp. 3385- 3390 ,(1986) , 10.1001/JAMA.1986.03370240055036
S.M Keller, M.G Vangel, S Adak, H Wagner, J.H Schiller, A Herskovic, R Komaki, M.C Perry, R.S Marks, R.B Livingston, D.H Johnson, The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer Lung Cancer. ,vol. 37, pp. 303- 309 ,(2002) , 10.1016/S0169-5002(02)00103-4
Clifton F. Mountain, Revisions in the International System for Staging Lung Cancer Chest. ,vol. 111, pp. 1710- 1717 ,(1997) , 10.1378/CHEST.111.6.1710